AstraZeneca will invest US$50bn in the US to expand manufacturing and research
Forexlive
AstraZeneca shares show signs of life after successful trials of hypertension drug
MarketWatch
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - CNBC
CNBC
AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year. https://t.co/b5hOwTxWaU https://t.co/Wq5EsZGLK5
@Reuters
AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition
SeekingAlpha
FibroGen sells China unit to AstraZeneca for $160 million
SeekingAlpha
AstraZeneca's Enhertu breast cancer drug added to China's state insurance list https://t.co/ANXcJ37J86 https://t.co/a5p6npwgWs
@Reuters
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
CNBC
AstraZeneca $AZN Q3 2024 earnings were released today before the market opened:
- Revenue: $13.56B vs $13.09B
- EPS: $1.04 vs $1.03 https://t.co/L9YMcRERaB
@Benzinga
AstraZeneca says detained China head has lawyer, but company still in dark https://t.co/e0JZ5gcq4d https://t.co/lqYDxOEImo
@Reuters
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
MarketWatch
AstraZeneca to pay up to $2 billion to license cardiovascular drug
MarketWatch
Sanofi, AstraZeneca win US approval for RSV therapy manufacturing line https://t.co/xnIivIV4Db https://t.co/myFZAy8W5A
@Reuters
US FDA approves AstraZeneca's non-small cell lung cancer treatment https://t.co/mkQJ7SUj5c https://t.co/d9xgiaNCJh
@Reuters
Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030
CNBC
AstraZeneca completes acquisition of Fusion Pharmaceuticals
SeekingAlpha
Ontario court approves AstraZeneca/Fusion acquisition plan
SeekingAlpha
Fusion shareholders give green light to AstraZeneca acquisition
SeekingAlpha
AstraZeneca to build $1.5 billion cancer drug manufacturing plant in Singapore - Reuters
Reuters
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial https://t.co/1HCc8JsuZy https://t.co/bHfQ2WNCOK
@Reuters
AstraZeneca to increase 2024 dividend by 7% on strong growth https://t.co/EwtVdAukKA https://t.co/0HTPRgW6KL
@Reuters
AstraZeneca will buy Fusion Pharmaceuticals for ~$2B
SeekingAlpha
AstraZeneca to expand rare disease pipeline with $1.05B Amolyt Pharma acquisition
SeekingAlpha
Gracell Biotechnologies receives shareholder approval for merger with AstraZeneca
SeekingAlpha
U.S. FDA approves AstraZeneca's Tagrisso-chemo combo https://t.co/KFPYOpWTGR https://t.co/RPuUvz1XQ1
@Reuters
Icosavax ticks lower as HSR filing for AstraZeneca deal withdrawn, refiled
SeekingAlpha
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK
MarketWatch
AstraZeneca to buy Gracell Biotechnologies for $1.2 billion
SeekingAlpha
Ionis Pharmaceuticals, AstraZeneca get FDA approval for rare genetic disease treatment
MarketWatch
Cytokinetics gains amid report of Novartis, AstraZeneca takeover interest
SeekingAlpha
AstraZeneca to acquire vaccine maker Icosavax in ~$1.1B deal
SeekingAlpha
Icosavax enters agreement to be acquired by Astrazeneca
SeekingAlpha
AstraZeneca partners with AI company to find cure for cancer
CoinTelegraph
AstraZeneca and Absci Collaborate on AI-Driven Cancer Therapy Development
Cryptopolitan
Drug Giant AstraZeneca Launches Evinova to Quicken Clinical Trials
Decrypt
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
CNBC
AstraZeneca prioritizes US for RSV drug amid surge in cases https://t.co/2KxUhShyqN https://t.co/mxvzb9oZ2C
@Reuters
AstraZeneca adds player to obesity drug race, but Eli Lilly remains in the lead
CNBC
AstraZeneca hikes earnings forecast as surging cancer drug sales offset plunging revenue from COVID vaccines
MarketWatch
AstraZeneca ups profit outlook on strong cancer drugs demand https://t.co/SJ29rHCteS https://t.co/wVyx5Ey8J0
@Reuters
Nanoform Grants AstraZeneca Global STARMAP AI License for Innovative Nanoparticle Medicine Development
Cryptopolitan
As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment
MarketWatch
AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations
CNBC
Stocks making the biggest moves in premarket trading: AstraZeneca, Paramount, Nike and more
CNBC
Stocks making the biggest moves premarket: AstraZeneca, Wayfair, Alibaba and more
CNBC
AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies
MarketWatch
AstraZeneca to buy Pfizer's rare disease gene therapy portfolio for up to $1 bln https://t.co/I8WZPzelun https://t.co/xgZG4kGfem
@Reuters
AstraZeneca shares slump after Phase 3 lung cancer drug study
MarketWatch
Movers & Shakers: Tesla shares rally on delivery numbers, AstraZeneca stock slumps on drug trial, and other stocks on the move
MarketWatch
AstraZeneca to decarbonize U.S. footprint by turning cow manure into renewable natural gas
MarketWatch
FAQ
Berapa harga saham AstraZeneca PLC hari ini?
Harga saat ini dari AstraZeneca PLC adalah 139.70 USD — telah menurun sebesar -1.63% dalam 24 jam terakhir. Lihat kinerja harga saham AstraZeneca PLC lebih dekat di chart lanjutan.
Apa simbol saham AstraZeneca PLC?
Tergantung pada bursa, simbol saham dapat bervariasi. Misalnya, di bursa PINK, saham AstraZeneca PLC diperdagangkan dengan simbol AZNCF.
Apakah harga saham AZNCF naik?
Saham AZNCF telah menurun sebesar 0.00% dalam minggu terakhir, telah meningkat sebesar 0.01% dalam bulan terakhir, dan telah menurun sebesar -9.46% dalam setahun terakhir. Lihat lebih banyak data di AZNCF chart.
Apa rekomendasi analis untuk AZNCF?
Per tanggal 22 Jul 2025, dari 49 rekomendasi analis, mayoritas memberikan nilai AZNCF sebagai buy.
Berapa kapitalisasi pasar AZNCF?
Hingga hari ini, AZNCF memiliki kapitalisasi pasar sebesar 220.16B USD. Jelajahi daftar saham kami yang diperingkat berdasarkan kapitalisasi pasar untuk membandingkan AZNCF dengan saham lainnya.
Apakah AZNCF merilis laporan keuangan?
Ya, Anda dapat melacak keuangan AZNCF dalam laporan tahunan dan kuartalan di Profit.com.
Kapan tanggal laporan pendapatan AZNCF berikutnya?
AZNCF akan merilis laporan pendapatan berikutnya pada 29 Jul 2025. Ikuti perkembangan acara mendatang dengan Kalender Pendapatan kami.
Berapa pendapatan AZNCF untuk kuartal terakhir?
AZNCF melaporkan pendapatan sebesar - per saham untuk kuartal terakhir, - dibandingkan dengan estimasi $2.14 per saham, menghasilkan kejutan -. Pendapatan yang diperkirakan untuk kuartal berikutnya adalah $2.23 per saham. Lihat lebih banyak detail tentang pendapatan AZNCF di Profit.com.
Berapa pendapatan AZNCF untuk kuartal terakhir?
Pendapatan AZNCF untuk kuartal terakhir adalah 13.59B USD, lebih rendah dibandingkan dengan estimasi 14.56B USD. Pendapatan yang diperkirakan untuk kuartal berikutnya adalah 14.46B USD. Lihat lebih banyak statistik di AZNCF laporan keuangan di Profit.com.
Berapa Laba Bersih AZNCF untuk kuartal terakhir?
Laba bersih AZNCF untuk kuartal terakhir adalah 2.99B USD, sementara kuartal sebelumnya menunjukkan laba bersih 1.5B USD yang mencatatkan perubahan sebesar 99.37%. Lihat lebih banyak statistik di AZNCF laporan keuangan di Profit.com.
Apakah AZNCF membayar dividen?
Ya, dividen AZNCF dibayar setiap kuartal. Dividen terakhir per saham adalah 3.1. Hingga hari ini, Dividend Yield (TTM)% adalah 2.31%.
Berapa banyak karyawan yang dimiliki AZNCF?
Hingga 22 Jul 2025, AZNCF mempekerjakan sekitar 94300 karyawan. Periksa apakah AZNCF ada dalam daftar pengusaha terbesar kami.
Apa itu EBITDA AZNCF?
EBITDA, yang mengukur kinerja operasional perusahaan, mencerminkan peningkatan efisiensinya. EBITDA AZNCF adalah 18.28B USD, dengan margin EBITDA saat ini sebesar 14.14%. Lihat lebih banyak statistik di laporan keuangan AZNCF di Profit.com.
Bagaimana cara membeli saham AZNCF?
Seperti saham lainnya, saham AZNCF diperdagangkan di bursa saham seperti PINK. Cara termudah untuk membelinya adalah melalui broker saham online. Cukup buka akun, ikuti prosedur broker, dan mulai berdagang. Sebagai alternatif, Anda dapat berlatih berdagang saham Tesla di Profit.com dalam Turnamen Playtrade atau memilih broker yang disarankan untuk berdagang langsung.
Haruskah saya berinvestasi di saham AZNCF?
Berinvestasi di saham membutuhkan penelitian yang mendalam, termasuk menganalisis keuangan perusahaan, berita terkait, dan analisis teknis. Saat ini, rekomendasi analis teknis Tesla menunjukkan rating buy.